Price data is not available
NextCure Inc
NXTCNASDAQ
NextCure (NXTC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.94 | $-1.82 | $-2.28 | $-4.01 |
| Actual | $-2.80 | $-1.87 | $-0.81 | $-3.22 |
| Surprise | -44.3% | -2.75% | +64.5% | +19.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.90 | $-0.79 | $-2.13 | $-2.21 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-2.80 | $-1.94 | -44.3 % |
| Q1 | May 7, 2026 | $-1.87 | $-1.82 | -2.75 % |
| Q4 | Mar 5, 2026 | $-0.81 | $-2.28 | 64.5 % |
| Q3 | Nov 5, 2025 | $-3.22 | $-4.01 | 19.7 % |
